MAPT and Alzheimer disease: In this regard, a prior study chronicled that amyloidogenic precursor protein (APP) and p-Tau, which are pivotal in the etiopathogenesis of AD, harbor KFERQ motifs, an attribute that facilitates their binding to LAMP2A to be marked for proteolytic degradation via CMA (Wang et al. 2009).